Cancer News and Research

Latest Cancer News and Research

Guidelines on cancer screenings spark debate

New guidelines on mammograms and pap smears set off a fierce debate.

20 Nov 2009

Study reveals effectiveness of radiation therapy in achieving local control and palliation in patients with PNTs

Radiation therapy is effective in achieving local control and palliation in patients with pancreatic neuroendocrine tumors (PNTs), despite such tumors being commonly considered resistant to radiation therapy, according to a largest of its kind study in the November 15 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

20 Nov 2009

A selection of today's opinions and editorials

These bills will provide a bedrock sense of security and stability for Americans who have health insurance, and quality, affordable options for Americans without it (Peter R. Orszag, 11/20).

20 Nov 2009

CVS/pharmacy kicks off its fundraiser for St. Jude Children's Research Hospital's annual campaign

CVS/pharmacy kicks off its annual in store fundraiser for the sixth year to support the St. Jude Children's Research Hospital Thanks and Giving campaign, beginning this Sunday and running through December 12. CVS/pharmacy store colleagues will encourage customers to add $1 to their purchase at the register to support the lifesaving research of St. Jude, one of the world's premier centers for the research and treatment of pediatric cancer and other catastrophic childhood diseases.

20 Nov 2009

Antigenics to withdraw its MAA for Oncophage following CHMP’s negative opinion

Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has formally adopted a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) as a treatment in earlier-stage, localized renal cell carcinoma (kidney cancer).

20 Nov 2009

FDA acknowledges Dendreon's amended BLA for PROVENGE as a complete response

Dendreon Corporation today announced that the U.S. Food and Drug Administration (FDA) provided written acknowledgement that the Company's amended Biologics License Application (BLA) for PROVENGE® (sipuleucel-T) is a complete response. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) date of May 1, 2010, by which time it will respond to Dendreon's amended BLA. Dendreon is seeking licensure for PROVENGE for men with metastatic castrate-resistant prostate cancer (CRPC).

20 Nov 2009

Boston Scientific's WallFlex Fully Covered Esophageal Stent receives FDA clearance and CE Mark approval

Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex® Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.

20 Nov 2009

Health policy research roundup

Urban Institute: Progress Enrolling Children in Medicaid/CHIP: Who Is Left And What Are The Prospects For Covering More Children? - This policy brief examines the characteristics of the estimated 5 million uninsured children who are eligible for CHIP/Medicaid in 2007 (64 percent of all uninsured children; 88 percent of all low-income uninsured children), but not enrolled.

20 Nov 2009

Genta announces preliminary results from study of Genasense Injection for advanced melanoma

Genta Incorporated announced preliminary results that show a high objective response rate in a pilot study of patients with advanced melanoma that incorporates the Company’s lead oncology product, Genasense® (oblimersen sodium) Injection, administered for the first time as a 1-hour high-dose intravenous (IV) infusion.

20 Nov 2009

Ligand Pharmaceuticals' SARM LGD-4033 study data presented at the Gerontology Society of America meeting

Ligand Pharmaceuticals Incorporated today announced that data from a preclinical study on its selective androgen receptor modulator (SARM) LGD-4033 was featured in a poster presentation at the 62nd Annual Meeting of the Gerontology Society of America in Atlanta. LGD-4033 exhibited desirable in vivo efficacy on skeletal muscle and bone measurements in animal models of male hypogonadism and postmenopausal osteoporosis.

20 Nov 2009

Soligenix receives $9.4M NIAID grant to develop technology for advancing rapidly acting vaccines

Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has formed a consortium to develop thermostable technology to advance RiVax(TM) and other rapidly acting vaccines. Soligenix received a $9.4 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to support this work.

20 Nov 2009

Inovio Biomedical announces positive test results of its consensus influenza vaccines

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that a combination of its synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and strains in ferrets.

20 Nov 2009

Quit smoking and get Karen Sokolof Javitch's "STAR TRACKS - THE TRIBUTE ALBUM" CD for free

Karen Sokolof Javitch is hoping that her new CD: STAR TRACKS - THE TRIBUTE ALBUM will encourage people to throw away their cigarettes! "It's worth a try," says Javitch, who decided to dedicate her CD to Patrick Swayze, who recently died of pancreatic cancer. "He was a 3-pack-a-day smoker, and never quit, even when he got sick." Her mother also died at age 56 (like Patrick) and she is sure cigarette smoking contributed to her death.

20 Nov 2009

German Research Foundation approves 9.4 million euros funding for University of Freiburg

The authorization committee of the German Research Foundation (DFG) has approved funding for a collaborative research center proposed by the University of Freiburg on the topic „Control of Cell Motility in Morphogenesis, Tumor Invasion, and Metastatic Spread" starting on 1 January 2010. The Freiburg SFB 850 will receive a total of 9.4 million euros in the next four years plus a 20 percent program allowance for indirect costs. In the case of success, the SFB 850 is eligible to receive funding for up to 12 years.

20 Nov 2009

2nd EMUC Meeting to discuss urological cancer

Experts agree that the urological cancer patient will benefit greatly if the delivered treatment is the result of a combined effort. Collaboration of experts from various fields is, therefore, necessary to take cancer-related research and medical practice to the next level.

20 Nov 2009

Only 1 in 4 Americans aged 50-64 regularly take advantage of preventive screenings, says report

Only about 1 in 4 Americans aged 50-64 regularly take advantage of preventive services such as screenings and immunizations, according to a report from the Centers for Disease Control and Prevention in collaboration with AARP and the American Medical Association (AMA).

20 Nov 2009

Twenty-five design teams compete in Brown School of Engineering Elevator Pitch Contest

Twenty-five Senior Design Teams competed for prizes Thursday night at Rice University's Brown School of Engineering Elevator Pitch Contest. The purpose of the contest was to get students to think about the commercial viability of their designs before building prototypes. Teams had 60 seconds to pitch their design project to an audience of local venture capitalists and business leaders.

20 Nov 2009

HHS Secretary commended for her statement on government medical panel

U.S. Health and Human Services Secretary Kathleen Sebelius is to be commended for publicly stating the government panel opposing mammograms is "an outside independent panel of doctors and scientists who ... do not set federal policy and ... don't determine what services are covered by the federal government."

20 Nov 2009

RaySearch Laboratories' interim report for the period January 1 – September 30, 2009

“It is extremely satisfying that the major development efforts during recent years are now beginning to pay off. In November our new product for Philips started generating revenues and we anticipate that the total revenue contribution from this and other new products will exceed SEK 10 M already in the fourth quarter,” says Johan Löf, President of RaySearch.

20 Nov 2009

U.S. District Court rules in favor of Cell Therapeutics to pursue all of its claims against The Lash Group

Cell Therapeutics, Inc. announced today that the Ninth Circuit Court of Appeals reversed a U.S. District Court order and ruled that CTI should be allowed to pursue all of its claims against The Lash Group, sending the case back to the District Court for trial. CTI filed a complaint against The Lash Group, CTI's former third-party reimbursement consultant for CTI's product TRISENOX, in 2007 seeking $22.8 million in damages for expenses already incurred related to the investigation, defense and a settlement of claims by the U.S. government concerning Medicare reimbursement for TRISENOX and other business losses.

20 Nov 2009

Cancer News and Research

Latest Cancer News and Research

Guidelines on cancer screenings spark debate

Study reveals effectiveness of radiation therapy in achieving local control and palliation in patients with PNTs

A selection of today's opinions and editorials

CVS/pharmacy kicks off its fundraiser for St. Jude Children's Research Hospital's annual campaign

Antigenics to withdraw its MAA for Oncophage following CHMP’s negative opinion

FDA acknowledges Dendreon's amended BLA for PROVENGE as a complete response

Boston Scientific's WallFlex Fully Covered Esophageal Stent receives FDA clearance and CE Mark approval

Health policy research roundup

Genta announces preliminary results from study of Genasense Injection for advanced melanoma

Ligand Pharmaceuticals' SARM LGD-4033 study data presented at the Gerontology Society of America meeting

Soligenix receives $9.4M NIAID grant to develop technology for advancing rapidly acting vaccines

Inovio Biomedical announces positive test results of its consensus influenza vaccines

Quit smoking and get Karen Sokolof Javitch's "STAR TRACKS - THE TRIBUTE ALBUM" CD for free

German Research Foundation approves 9.4 million euros funding for University of Freiburg

2nd EMUC Meeting to discuss urological cancer

Only 1 in 4 Americans aged 50-64 regularly take advantage of preventive screenings, says report

Twenty-five design teams compete in Brown School of Engineering Elevator Pitch Contest

HHS Secretary commended for her statement on government medical panel

RaySearch Laboratories' interim report for the period January 1 – September 30, 2009

U.S. District Court rules in favor of Cell Therapeutics to pursue all of its claims against The Lash Group

Cancer Research - Second Edition eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in